[go: up one dir, main page]

DK3347030T3 - Brug af pasteuriseret akkermansia til behandling af stofskiftesygdomme - Google Patents

Brug af pasteuriseret akkermansia til behandling af stofskiftesygdomme Download PDF

Info

Publication number
DK3347030T3
DK3347030T3 DK16763806.3T DK16763806T DK3347030T3 DK 3347030 T3 DK3347030 T3 DK 3347030T3 DK 16763806 T DK16763806 T DK 16763806T DK 3347030 T3 DK3347030 T3 DK 3347030T3
Authority
DK
Denmark
Prior art keywords
metable
diseases
treatment
pasteurized akkermansia
akkermansia
Prior art date
Application number
DK16763806.3T
Other languages
English (en)
Inventor
Clara Belzer
Vos Willem De
Patrice Cani
Amandine Everard
Hubert Plovier
Céline Druart
Original Assignee
Univ Catholique Louvain
Univ Wageningen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=54145609&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3347030(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Catholique Louvain, Univ Wageningen filed Critical Univ Catholique Louvain
Application granted granted Critical
Publication of DK3347030T3 publication Critical patent/DK3347030T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/308—Foods, ingredients or supplements having a functional effect on health having an effect on cancer prevention
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/332—Promoters of weight control and weight loss
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Birds (AREA)
  • Physiology (AREA)
  • Botany (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
DK16763806.3T 2015-09-10 2016-09-09 Brug af pasteuriseret akkermansia til behandling af stofskiftesygdomme DK3347030T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15184758 2015-09-10
PCT/EP2016/071327 WO2017042347A1 (en) 2015-09-10 2016-09-09 Use of pasteurized akkermansia for treating metabolic disorders

Publications (1)

Publication Number Publication Date
DK3347030T3 true DK3347030T3 (da) 2021-08-09

Family

ID=54145609

Family Applications (2)

Application Number Title Priority Date Filing Date
DK16763806.3T DK3347030T3 (da) 2015-09-10 2016-09-09 Brug af pasteuriseret akkermansia til behandling af stofskiftesygdomme
DK19201220.1T DK3626081T3 (da) 2015-09-10 2016-09-09 Pasteuriseret akkermansia til fremme af vægttab

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK19201220.1T DK3626081T3 (da) 2015-09-10 2016-09-09 Pasteuriseret akkermansia til fremme af vægttab

Country Status (17)

Country Link
US (2) US10736924B2 (da)
EP (3) EP3943093A1 (da)
JP (2) JP6954563B2 (da)
KR (5) KR102581908B1 (da)
CN (2) CN114276960A (da)
AU (2) AU2016319221B2 (da)
BR (1) BR112018004532B1 (da)
CA (1) CA2998039A1 (da)
DK (2) DK3347030T3 (da)
EA (1) EA201800199A1 (da)
ES (2) ES2908310T3 (da)
HK (1) HK1257222A1 (da)
IL (1) IL257978B (da)
MX (1) MX394909B (da)
PL (2) PL3347030T3 (da)
PT (2) PT3347030T (da)
WO (1) WO2017042347A1 (da)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4529950A2 (en) 2014-10-31 2025-04-02 Pendulum Therapeutics, Inc. Methods and compositions relating to microbial treatment
ES2934138T3 (es) 2015-05-06 2023-02-17 Univ Wageningen Uso de un polipéptido para efectuar la señalización inmunitaria y/o afectar la función de la barrera intestinal y/o modular el estado metabólico
SG11201708706YA (en) 2015-05-06 2017-11-29 Snipr Tech Ltd Altering microbial populations & modifying microbiota
EP3943093A1 (en) * 2015-09-10 2022-01-26 Université catholique de Louvain Use of pasteurized akkermansia for treating cancer
WO2017178496A1 (en) * 2016-04-11 2017-10-19 Wageningen Universiteit Novel bacterial species
GB201609811D0 (en) 2016-06-05 2016-07-20 Snipr Technologies Ltd Methods, cells, systems, arrays, RNA and kits
CA3211208A1 (en) 2017-04-03 2018-10-11 Gusto Global, Llc Rational design of microbial-based biotherapeutics
TWI636788B (zh) * 2017-08-28 2018-10-01 長庚生物科技股份有限公司 戈氏副擬桿菌用於抑制脂肪肝疾病之用途
AU2018326705A1 (en) 2017-08-30 2020-03-05 Pendulum Therapeutics, Inc. Methods and compositions for treatment of microbiome-associated disorders
EP3690026A4 (en) 2017-09-28 2021-06-23 Kobiolabs, Inc. COMPOSITION FOR THE DIAGNOSIS AND TREATMENT OF ALCOHOLIC LIVER DISEASE USING A MODIFICATION IN THE SHORT CHAIN FATTY ACID-PRODUCING INTESTINAL COMMUNITY
US10760075B2 (en) 2018-04-30 2020-09-01 Snipr Biome Aps Treating and preventing microbial infections
CN113038957A (zh) 2018-04-10 2021-06-25 谢尔塔治疗公司 微生物群
KR102377407B1 (ko) * 2018-10-01 2022-03-22 한국생명공학연구원 아커만시아 뮤시니필라 균주 또는 이의 배양물을 유효성분으로 함유하는 노화방지용 조성물
KR102197180B1 (ko) * 2018-10-11 2020-12-31 주식회사 고바이오랩 아커만시아 뮤시니필라 균주 및 이를 포함하는 식욕 억제 및 대사성 질환 예방, 개선, 완화 및 치료용 조성물
CN109259240A (zh) * 2018-10-12 2019-01-25 人和未来生物科技（长沙）有限公司 调节肠道菌群和防治肥胖的组合物及其应用
US11851663B2 (en) 2018-10-14 2023-12-26 Snipr Biome Aps Single-vector type I vectors
FR3099054A1 (fr) * 2019-07-24 2021-01-29 Institut National De La Recherche Agronomique (Inra) Souche de Christensenella pour son utilisation dans le traitement et la prévention d’une inflammation gastro-intestinale
WO2020226438A1 (ko) * 2019-05-07 2020-11-12 한국생명공학연구원 염증성 장질환의 예방 또는 치료용 펩타이드
KR102128289B1 (ko) * 2019-08-23 2020-06-30 주식회사 엔테로바이옴 아커만시아 뮤시니필라 eb-amdk27 균주 및 그의 용도
KR102128287B1 (ko) * 2019-08-23 2020-06-30 주식회사 엔테로바이옴 아커만시아 뮤시니필라 eb-amdk19 균주 및 그의 용도
CN110679949A (zh) * 2019-09-30 2020-01-14 山东晶辉生物技术有限公司 一种减肥组合物及其制备方法
KR102397916B1 (ko) * 2019-10-01 2022-05-17 (주)헬스바이옴 건강한 임산부 모유 유래 혐기성 인체 균주 및 이를 이용한 대사성 질환의 예방 또는 치료방법
EP4041264A1 (en) 2019-10-07 2022-08-17 Siolta Therapeutics, Inc. Therapeutic pharmaceutical compositions
CN110786376A (zh) * 2019-11-07 2020-02-14 中南大学湘雅医院 嗜黏蛋白艾克曼氏灭活菌在制备酸奶中的应用及酸奶的制备方法和应用
AU2020412484A1 (en) * 2019-12-23 2022-08-18 Pendulum Therapeutics, Inc. Compositions comprising microbes and methods of use and making thereof
KR20220164002A (ko) * 2020-04-03 2022-12-12 듀폰 뉴트리션 바이오사이언시즈 에이피에스 대사 건강 개선용 박테리아 균주를 포함하는 조성물
WO2021215828A1 (ko) 2020-04-24 2021-10-28 주식회사 고바이오랩 Glp-1 유도 활성을 갖는 단백질 변이체 및 이의 용도
KR102309911B1 (ko) * 2020-05-11 2021-10-07 재단법인 아산사회복지재단 신규한 아커만시아 뮤시니필라 ak32 균주의 발견 및 장 손상의 예방 또는 치료를 위한 응용
KR102185827B1 (ko) * 2020-08-26 2020-12-03 주식회사 엔테로바이옴 아커만시아 뮤시니필라 균주를 포함하는 아토피성 질환 예방 또는 치료용 약학적 조성물
BE1028339B1 (fr) 2020-11-09 2021-12-21 A Mansia Biotech Composition comprenant de l'Akkermansia muciniphila et de l'extrait de thé vert
BE1028330B1 (fr) * 2020-11-09 2021-12-17 A Mansia Biotech Composition comprenant de l'Akkermansia muciniphila et de l'extrait de camu camu
CN113041214A (zh) * 2021-03-16 2021-06-29 中南大学湘雅医院 一种负载嗜粘蛋白-艾克曼菌的改性透明质酸水凝胶及其制备方法和应用
CN113116936A (zh) * 2021-04-02 2021-07-16 上海市第六人民医院 嗜黏蛋白艾克曼氏菌在制备β-鹅脱氧胆酸抑制剂中的应用
CN113265359A (zh) * 2021-05-26 2021-08-17 广西壮族自治区兽医研究所 一种改良的嗜黏蛋白阿克曼氏菌液体培养方法
BE1029496B1 (fr) 2021-08-19 2023-01-16 The Akkermansia Company Composition comprenant de l'Akkermansia muciniphila pasteurisée pour le traitement ou la prévention des troubles de la contractilité intestinale, en particulier des troubles de l'amplitude de la contractilité duodénale
BE1029502B1 (fr) 2021-08-19 2023-01-17 The Akkermansia Company Composition comprenant de l'Akkermansia muciniphila pasteurisée pour le traitement ou la prévention de l'anxiété liée au syndrome du côlon irritable
FR3129831B1 (fr) 2021-12-07 2025-04-11 Activinside Utilisation d’une composition à base de Crocus sativus comme prébiotique
US12156859B2 (en) * 2021-12-20 2024-12-03 Tainnovation Inc. Methods of and compositions for treating obesity, obesity-related diseases or cancers using a N6-methyllysine/l-lysine mixture
CN114949003B (zh) * 2022-06-08 2024-03-19 广州知易生物科技有限公司 嗜粘蛋白阿克曼菌及其应用和培养方法
CN114949002B (zh) * 2022-06-08 2024-03-19 广州知易生物科技有限公司 嗜粘蛋白阿克曼菌在制备防治动脉粥样硬化的组合物中的应用
CN115612635B (zh) * 2022-06-23 2024-08-27 济南大学 一种嗜黏蛋白艾克曼菌ww001及其组合物、复合菌剂与应用
GB202209518D0 (en) 2022-06-29 2022-08-10 Snipr Biome Aps Treating & preventing E coli infections
CN116925975B (zh) * 2023-08-18 2024-01-23 善恩康生物科技（苏州）有限公司 一种Akkermansia muciniphila及其产品和应用
CN116999468B (zh) * 2023-08-18 2024-11-15 善恩康生物科技（苏州）有限公司 Akkermansia muciniphila在制备预防、治疗和/或辅助治疗心血管疾病的产品中的应用
CN118178476A (zh) * 2024-04-03 2024-06-14 暨南大学附属第一医院（广州华侨医院） 阿克曼菌及其制剂在制备促进排便、排脂、减少肠道脂肪吸收的药物中的应用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003303894A1 (en) * 2003-01-30 2004-08-30 The Regents Of The University Of California Inactivated probiotic bacteria and methods of use thereof
EP1931363B1 (en) * 2005-09-28 2015-11-18 Nordisk Rebalance A/S Treatment of ibd using both probiotic bacteria and fermented cereal as treatment effectors
EP2102350A4 (en) 2006-12-18 2012-08-08 Univ St Louis DARMMICROBIOMA AS A BIOMARKER AND THERAPEUTIC OBJECT FOR THE TREATMENT OF ADIPOSITAS OR ADIPOSITASCONDUCTIVE DISEASES
EP2030623A1 (en) 2007-08-17 2009-03-04 Nestec S.A. Preventing and/or treating metabolic disorders by modulating the amount of enterobacteria
FR2944524B1 (fr) 2009-04-17 2012-11-30 Ipsen Pharma Sas Derives d'imidazolidine-2,4-dione et leur utilisation comme medicament
MY165388A (en) 2009-05-11 2018-03-21 Nestec Sa Lactobacillus johnsonii la1 ncc533 (cncm i-1225) and immune disorders
US9150889B2 (en) * 2010-01-15 2015-10-06 The Regents Of The University Of California Electro-autotrophic synthesis of higher alcohols
ES2565407T3 (es) * 2010-11-05 2016-04-04 Nestec S.A. Procedimiento para la preparación de un producto alimenticio para animales de compañía, el cual contiene microorganismos probióticos
EP2449891A1 (en) * 2010-11-05 2012-05-09 Nestec S.A. Drinking yoghurt preparations containing non-replicating probiotic micro-organisms
AU2011328041A1 (en) * 2010-11-11 2013-05-23 Nestec S.A. Spoonable yogurt preparations containing non-replicating probiotic micro-organisms
JP5813976B2 (ja) * 2011-03-29 2015-11-17 ユニ・チャーム株式会社 ペット用おむつ
WO2012170478A2 (en) * 2011-06-06 2012-12-13 The University Of North Carolina At Chapel Hill Methods and kits for detecting adenomas, colorectal cancer, and uses thereof
CN110201003A (zh) * 2012-02-29 2019-09-06 伊西康内外科公司 微生物区系的组合物及与其相关的方法
WO2014007606A1 (en) * 2012-07-05 2014-01-09 N.V. Nutricia Product for use in the prophylactic or therapeutic treatment of a negative emotion or introvert behaviour
CN104540962B (zh) * 2012-08-01 2017-09-19 深圳华大基因研究院 糖尿病生物标志物及其应用
WO2014075745A1 (en) * 2012-11-19 2014-05-22 Université Catholique de Louvain Use of akkermansia for treating metabolic disorders
WO2014201037A2 (en) * 2013-06-10 2014-12-18 New York University Methods for manipulating immune responses by altering microbiota
CN116270718A (zh) * 2015-04-23 2023-06-23 Dsm营养产品有限责任公司 聚糖治疗剂和治疗方法
ES2934138T3 (es) * 2015-05-06 2023-02-17 Univ Wageningen Uso de un polipéptido para efectuar la señalización inmunitaria y/o afectar la función de la barrera intestinal y/o modular el estado metabólico
EP3943093A1 (en) * 2015-09-10 2022-01-26 Université catholique de Louvain Use of pasteurized akkermansia for treating cancer
US10537597B2 (en) * 2015-10-05 2020-01-21 Schweizerisches Forschungsinstitut Fur Hochgebrigsklima Und Medizin In Davos Use of Akkermansia muciniphila for treating inflammatory conditions
AU2021299904A1 (en) * 2020-07-01 2023-01-19 Advanced Microbiome Interventions B.V. Amuc-1100 polypeptide variants for effecting immune signalling and/or affecting intestinal barrier function and/or modulating metabolic status
CN113862193B (zh) * 2021-10-28 2023-12-22 江西普瑞森基因科技有限公司 一株嗜黏蛋白阿克曼氏菌及其在制备抗肿瘤药物中的应用

Also Published As

Publication number Publication date
KR20230070053A (ko) 2023-05-19
PT3626081T (pt) 2022-02-25
PT3347030T (pt) 2021-08-19
PL3347030T3 (pl) 2021-11-22
KR20230125340A (ko) 2023-08-29
CN108289918A (zh) 2018-07-17
ES2883231T3 (es) 2021-12-07
US20210015876A1 (en) 2021-01-21
HK1257222A1 (zh) 2019-10-18
CN108289918B (zh) 2022-01-18
EP3626081A1 (en) 2020-03-25
KR102569754B1 (ko) 2023-08-23
AU2016319221A1 (en) 2018-03-29
DK3626081T3 (da) 2022-02-28
US20180250347A1 (en) 2018-09-06
MX394909B (es) 2025-03-24
BR112018004532B1 (pt) 2022-03-15
EP3347030B1 (en) 2021-07-14
EP3943093A1 (en) 2022-01-26
IL257978A (en) 2018-05-31
JP2019500004A (ja) 2019-01-10
KR20240137695A (ko) 2024-09-20
KR102581908B1 (ko) 2023-09-22
KR20220148941A (ko) 2022-11-07
EA201800199A1 (ru) 2018-12-28
AU2022203731B2 (en) 2025-02-27
JP2022000040A (ja) 2022-01-04
CN114276960A (zh) 2022-04-05
PL3626081T3 (pl) 2022-04-25
IL257978B (en) 2021-12-01
BR112018004532A2 (pt) 2018-12-11
KR102530852B1 (ko) 2023-05-12
MX2018002990A (es) 2018-06-08
AU2016319221B2 (en) 2022-06-30
EP3626081B1 (en) 2022-02-09
CA2998039A1 (en) 2017-03-16
AU2022203731A1 (en) 2022-06-23
KR20180053336A (ko) 2018-05-21
WO2017042347A1 (en) 2017-03-16
JP6954563B2 (ja) 2021-10-27
ES2908310T3 (es) 2022-04-28
US10736924B2 (en) 2020-08-11
EP3347030A1 (en) 2018-07-18

Similar Documents

Publication Publication Date Title
DK3347030T3 (da) Brug af pasteuriseret akkermansia til behandling af stofskiftesygdomme
HUE064141T2 (hu) Azolopirimidin rákkal összefüggõ rendellenességek kezelésére
DK3173092T3 (da) Rna-holdig sammensætning til behandling af tumorsygdomme
DK3212233T3 (da) Kombinationsterapi til behandling af sygdom
EP3263132C0 (en) Composition for treating il-6-related diseases
DK3240612T3 (da) Fremgangsmåder til behandling af nethindesygdomme
PL3265053T3 (pl) Sposoby leczenia skóry
HUE055263T2 (hu) 11-Szubsztituált 24-hidroxiszterolok NMDA-hoz kapcsolódó állapotok kezelésére
EP3601536A4 (en) TREATMENT PROCESSES
HUE059694T2 (hu) Készítmény rák kezelésére
HK1251482A1 (zh) 用於治療補體介導的疾病的組合物和方法
DK3474802T3 (da) Medicinsk forbinding
DK3390390T3 (da) Bipyrazolylderivater egnede til behandling af autoimmunsygdomme
DK3362066T3 (da) Kombinationsterapi til behandling af maligniteter
HUE050944T2 (hu) Kezelési eljárás tradipitant alkalmazásával
BR112016022976A2 (pt) Métodos para o tratamento de hcv
HUE060517T2 (hu) Immunhiányos betegség kezelésére szolgáló eljárások
DK3578562T3 (da) L-valinatamidbenzoxaborolderivater til behandling af parasitiske sygdomme
DK3097085T3 (da) Benzoxazinonderivater til behandling af hudsygdomme
IL257764B (en) Methods for treatment of diseases
DK3157522T3 (da) Muskarin-antagonister og kombinationer deraf til behandlingen af luftvejssygdomme i heste
DK3331610T3 (da) Midler til anvendelse til behandling af gliom
EP3597225A4 (en) TREATMENT PROCESS
DK3169405T3 (da) Fremgangsmåder, forbindelser og sammensætninger til behandling af muskel- og skeletsygdomme
DE112015002229A5 (de) Formulierungen zur Behandlung von Hyperthyreose